Actualités et Activités de BioNano Genomics
Présence
Siège : Etats—Unis
BioNano Genomics est une société cotée sous le symbole boursier BNGO (US).
Dirigeants
Voir l'organigramme avec ses 21 principaux dirigeants
Biographies les plus recherchées chez BioNano Genomics
- Albert Luderer, Interim Chief Executive Officer and Chairman of t...
- David Barker, Director
- Kristiina Vuori, Director
Changements de dirigeants chez BioNano Genomics
- Alka Chaubey, Chief Medical Officer, a quitté l'entreprise (publié le 6 juillet 2026).
- Alex Hastie, a rejoint l'entreprise comme Chief Scientific Officer (publié le 25 juin 2026).
- Christopher Twomey qui était Director, devient Lead Independent Director (publié le 8 mai 2026).
Cliquez ici pour voir d'autres changements chez BioNano Genomics
Créer une alerte
pour suivre les mouvements de dirigeants chez BioNano Genomics.
Biotechnologie
BioNano Genomics a 2 428 concurrents dont Lonza (Suisse), Vertex Pharmaceuticals (Etats—Unis) et Eurofins (Luxembourg).
Actualités en fusion/acquisition en Biotechnologie.
- Eli Lilly has announced the acquisition of AtaiBeckley (publié le 17 juillet 2026).
- GSK a acquis Nuvalent (publié le 17 juillet 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publié le 15 juillet 2026).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de BioNano Genomics
- BioNano Genomics sur Wikipédia, Google News & Yahoo Finance en 1-click
- BioNano Genomics sur LinkedIn, X (Twitter) & YouTube en 1-click
